Vaccination with Tetanus, Diphtheria, and Acellular Pertussis Vaccine of Pregnant Women Enrolled in Medicaid — Michigan, 2011–2013

In October 2011, the Advisory Committee on Immunization Practices (ACIP) first recommended the routine administration of a tetanus, diphtheria, and acellular pertussis vaccine (Tdap) during pregnancy as a strategy to protect infants from pertussis (also known as whooping cough). This recommendation applied to women previously unvaccinated with Tdap and specified the optimal vaccination time as late second or third trimester (after 20 weeks' gestation). By vaccinating pregnant women, infants, who are at highest risk for mortality and morbidity from pertussis, gain passive immunity from maternal antibodies transferred to them in utero. Since this recommendation was made, little has been published on the percentage of women receiving Tdap during pregnancy. In Michigan, Medicaid pays for costs of pregnancy for approximately 40% of births. Infants enrolled in Medicaid are a particularly vulnerable population; in Michigan, their all-cause mortality is higher than that of privately insured infants. To assess vaccination coverage among pregnant women enrolled in a publicly funded insurance program in Michigan, Medicaid administrative claims data and statewide immunization information system data for mothers of infants born during November 2011-February 2013 were analyzed. This report describes the results of that analysis, which indicated that only 14.3% of these women received Tdap during pregnancy, with rates highest (17.6%) among non-Hispanic, non-Arab whites and lowest (6.8%) among Arab women. Vaccination was related to maternal age and gestational age at birth, but not to adequacy of prenatal care. In 2013, recognizing the importance of Tdap for every pregnancy, ACIP revised its guidelines to include a Tdap dose during every pregnancy. Ensuring that all infants receive the protection against pertussis afforded by maternal vaccination will require enhanced efforts to vaccinate pregnant women.

[1]  Craig M. Hales,et al.  Noninfluenza Vaccination Coverage Among Adults — United States, 2012 , 2014, MMWR. Morbidity and mortality weekly report.

[2]  M. Decker,et al.  Immune Responses in Infants Whose Mothers Received Tdap Vaccine During Pregnancy , 2013, The Pediatric infectious disease journal.

[3]  J. Nordin,et al.  Influenza and Pertussis Vaccination Coverage Among Privately Insured Women of Reproductive Age , 2013, Maternal and Child Health Journal.

[4]  L. Grohskopf,et al.  Influenza Vaccination Coverage Among Pregnant Women — United States, 2012–13 Influenza Season , 2013, MMWR. Morbidity and mortality weekly report.

[5]  C. Baker,et al.  Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Pichichero,et al.  Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. , 2011, American journal of obstetrics and gynecology.

[7]  M. Kotelchuck,et al.  An evaluation of the Kessner Adequacy of Prenatal Care Index and a proposed Adequacy of Prenatal Care Utilization Index. , 1994, American journal of public health.

[8]  Advisory Committee on Immunization Practices (ACIP) recommended immunization schedules for persons aged 0 through 18 years and adults aged 19 years and older--United States, 2013. , 2013, MMWR Supplements.